Page last updated: 2024-12-11
dykellic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
dykellic acid: an apoptosis inhibitor isolated from Westerdykella multispora; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6397984 |
CHEMBL ID | 449742 |
MeSH ID | M0360000 |
Synonyms (5)
Synonym |
---|
3-[5-methylidene-2-oxo-6-[(1e,3e)-penta-1,3-dienyl]pyran-3-yl]propanoic acid |
CHEMBL449742 |
dykellic acid |
3-(5-methylene-2-oxo-6-((1e,3e)-penta-1,3-dien-1-yl)-5,6-dihydro-2h-pyran-3-yl)propanoic acid |
1097679-78-1 |
Research Excerpts
Overview
Dykellic acid is a novel microbial metabolite isolated from the broth of Westerdykella multispora.
Excerpt | Reference | Relevance |
---|---|---|
"Dykellic acid is a novel microbial metabolite isolated from the broth of Westerdykella multispora F50733. " | ( Dykellic acid inhibits drug-induced caspase-3-like protease activation. Kho, YH; Kim, HM; Kim, SU; Lee, HJ; Lee, SH; Youk, ES, 2003) | 3.2 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (11)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID412555 | Inhibition of recombinant caspase 3 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-DEVD-pNA substrate up to 100 uM | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412559 | Cytoprotective activity against 20 uM rotenone-induced intracellular ROS production in human U937 cells at 100 uM pretreated for 5 hrs by 2,7-dichlorodihydrofluorescein dye reduction assay | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412556 | Inhibition of recombinant caspase 6 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-VEID-pNA substrate up to 100 uM | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412558 | Inhibition of recombinant caspase 8 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-IETD-pNA substrate up to 100 uM | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412554 | Antiapoptotic activity in human U937 cells assessed as reduction of 1.5 uM etoposide-induced caspase-3/7 like activity at 100 nM pretreated for 5 hrs measured after 24 hrs relative to control | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412551 | Cytoprotective activity against 50 uM N-methyl-N'-nitro-N-nitrosoguanidine-induced cell death in human U937 cells pretreated for 5 hrs measured after 24 hrs by cell flow cytometry using propidium iodide staining relative to control | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412552 | Cytoprotective activity against 50 uM H2O2-induced cell death in human U937 cells pretreated for 5 hrs measured after 24 hrs by cell flow cytometry using propidium iodide staining relative to control | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412557 | Inhibition of recombinant caspase 7 activity expressed in Escherichia coli BL21 (DE3) assessed as p-nitroaniline release using Ac-DEVD-pNA substrate up to 100 uM | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412549 | Cytoprotective activity against 5 uM rotenone-induced cell death in human U937 cells pretreated for 5 hrs measured after 24 hrs by cell flow cytometry using propidium iodide staining relative to control | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412765 | Cytoprotective activity against 20 uM rotenone-induced intracellular ROS production in human U937 cells at 100 uM pretreated for 5 hrs by dihydroethidium dye reduction assay | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
AID412553 | Antiapoptotic activity in human U937 cells assessed as reduction of 1.5 uM etoposide-induced caspase-3/7 like activity pretreated for 5 hrs measured after 24 hrs relative to control | 2009 | Journal of medicinal chemistry, Jan-08, Volume: 52, Issue:1 | Total synthesis and cytoprotective properties of dykellic acid. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.99
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.99) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |